Coagulation Disorders near Rego Park, NY

Care Philosophy: I have been Service Chief of the BenignHematology Service in the Division of Hematology and Medical Oncology since 2006. As a clinician, my main interest is in the care of patients with thrombotic and bleeding disorders. As a researcher who conducts clinical trials in Benign Hematology, my interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. It is my hope that through dedication to the care of each individual patient, and dedication to research that will ultimately improve that care, we will meet our overall mission of helping our patients to have a better quality of life.

Biography: Dr. Howard Greenberg, MD is a Hematology Specialist who practices in Astoria, NY. He is 77 years old and has been practicing for 52 years. Dr. Howard Greenberg, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Biography: Pinkal Desai MD, MPH is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital.After obtaining her MBBS at Byramjeejeebhoy Medical College in India in 2005, Dr. Desai obtained an MPH at the University of Alabama at Birmingham School of Public Health. Following her residency at Wayne State University, Detroit Medical Center, she underwent fellowship training in Hematology-Medical Oncology at Providence Hospital Medical Center, serving as Chief Fellow from 2012-2013. Dr. Desai was recruited to serve in our Leukemia Program to develop a clinical practice devoted to leukemia, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). She will be developing clinical and translational research protocols and projects in the areas of leukemia, MDS and MPN.Dr. Desai is published in Cancer Epidemiology Biomarkers Prevention and International Journal of Molecular Epidemiology and Genetics. She is the lead author and co-author on numerous WHI (Women's Health Initiative) paper proposals and has presented abstracts at national meetings. She is a member of American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) and has served on the ASCO University Committee.

Biography: Fellowship: Hematology/Oncology at New York Presbyterian Hospital, 1997-2000Residency: New York Presbyterian Hospital, 1995-97Internship: The Beth Israel Hospital, Boston 1994-95Medical School: The Mount Sinai School of Medicine, New York, 1994Undergraduate: Yale University, 1990

Care Philosophy: Our Lymphoma group has been at the forefront in the development of targeted therapies for CLL and other lymphoid malignancies. We strive to bring effective therapeutics to patients, years before they are widely available. I am fortunate to practice oncology in such an exciting era with rapidly improving diagnostic and therapeutic options. I seek to incorporate the latest breakthroughs and technology in providing care to my patients. Comprehensive in my approach, I am driven to understand the underlying biology of the disease, individualizing each patient's treatment plan. I offer patients a unique experience, with compassion for the patient and their family. With a large portfolio of clinical trials, our group offers ample opportunities for patients to participate in clinical research. Our hospital system is award winning and provides access to world-class consultants for all medical conditions. It will be a privilege to care for you or your family member.

Biography: Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicineand a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.For More Videos, please see below:Lymphoma Cancer Treatment NY - Weill Cornell

Care Philosophy: nbsp; It takes a village to achieve the best care of patients in their battle against complicated blood disorders I am privileged to work in a world class medical institution which not only assures a multidisciplinary approach for patient treatment

Biography: Michael S. Samuel, M.D. is an Assistant Professorof Clinical Medicine at Weill Cornell Medical College and Assistant Attending Physician at New York Presbyterian Hospital. Dr. Samuel took an indirect route to medicine, initially receiving his B.A. in English and Anthropology from Union College. He worked as a treatment counselor for developmentally disabled at-risk youth, and then as a teacher of English as a foreign language in Shenzhen, China.Dr. Samuel subsequently joined the leukemia program at Weill Cornell Medical College as a clinical trials research assistant while completing post-baccalaureate studies at Columbia University. He then received his MD from SUNY Downstate Medical Center College of Medicine in 2009. Thereafter, Dr. Samuel completed both his residency in internal medicine and fellowship in Hematology/Oncology at Montefiore Medical Center. His medical training also included experiences studying acupuncture in Beijing, China, and service as a physician on the medical ward at Kisoro District Hospital in Uganda.Throughout his medical training Dr. Samuel maintained a focus on hematological malignancies and spent his final year of fellowship in the lab of Kira Gritsman, MD, PhD, at Albert Einstein Cancer Center studying the genetic determinants of PI3 kinase pathway dependence in leukemic development. Dr. Samuel now rejoins the Leukemia Program in the division of Hematology/Oncology at Weill Cornell Medical College where he will specialize in the treatment of patients with leukemia, myelodysplasia and myeloproliferative neoplasms, and will be actively involved in the clinical trials research within the program.

Care Philosophy: Dr. Ritchie's research interests are in the treatment of older patients with anemia, cytopenias, myelodysplastic syndromes, myeloproliferative disorders and acute leukemia. She is interested in finding better therapies and supportive care strategies for older patients. Dr. Ritchie is the principal investigator on clincal trials investigating new diagnostic techniques, supportive care strategies and therapeutics aimed at the older patient. She collaborates with investigators in the Division of Geriatrics and Gerontology. She has been the author or co-author of many publications. She is interested in improving the medical care of older patients with hematologic malignancies.

Care Philosophy: Dr. Landres offers expertise in all aspects of high risk obstetrics, performs obstetric ultrasound, prenatal diagnosis procedures including amniocentesis, and cerclage placement. Her special interests include management of diabetes in pregnancy, hypertensive disorders, autoimmune disorders and fetal growth restriction. Dr. Landres is committed to providing high quality, compassionate care and supporting her patients throughout pregnancy and post-partum.

Biography: Dr. Shipra Kaicker is an Associate Professor of Clinical Pediatrics at Weill Cornell Medicine and Associate Attending Pediatrician at NewYork-Presbyterian Hospital. Her clinical areas of interest are pediatric hematology, platelet disorders, immune cytopenias, anemias, sickle cell disease and bone marrow failure syndromes. She is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kaicker received her M.B.B.S. degree at Lady Hardinge Medical College at the University of Delhi, New Delhi, India. She completed her M.D. and Pediatric Residency at Maulana Azad Medical College, also at the University of New Delhi, where she also served as Senior Registrar (Chief Resident) in Pediatrics. Dr. Kaicker expanded her training in New York City, where she completed a Post-Doctoral Clinical Fellowship and Post-Doctoral Research Fellowship, both in Pediatric Hematology-Oncology, at Columbia University Medical Center, and an additional Pediatric Residency at Saint Vincent's Medical Center. Dr. Kaicker is a clinical researcher and is participating in clinical trials for childhood immune thrombocytopenia as part of ICON ( ITP Consortium of North America) and collaborating with basic science researchers to identify biomarkers in childhood ITP

Care Philosophy: My first priority is the patient sitting in front of me. I have a longstanding interest in cancer care and have been specifically focused on lymphoma since my father was diagnosed with Hodgkin lymphoma when I was a medical student. At Weill Cornell, our experienced team of lymphoma specialists works together to determine the most appropriate therapy for each individual patient. Our group has played a key role in the development of many new therapies approved for lymphoma in recent years. As a result, our patients have early access to new and promising lymphoma treatments. We are fortunate to have a strong team of physician assistants, nurses, medical technicians, pharmacists, and administrative staff. This environment enables me to provide my patients with the best possible level of care.

Care Philosophy: I realize how scary it can be to receive a life-threatening diagnosis, and firmly believe in taking the time to clearly communicate with my patients about the nature of their disease and their various treatment options. This can not only vastly improve our patients' experiences, but also their treatment outcomes, as an educated patient is able to make informed decisions about care and reclaim some of the autonomy that can be lost when coping with a cancer diagnosis. In the midst of all the cutting-edge science and technology that we offer, I find it extremely important to remember that it is the patient who is the center of it all. I genuinely care about my patients, and instilling a sense of hope, sharing a laugh, or a kind word can be as important as all the medical advances and state-of-the-art science.